U.S. Conglomerate Wal-Mart is Participating in MEDILEDGER, A Consortium of Tracking Blockchain for Pharmaceuticals.

It has been confirmed that Wal-Mart, a U.S. conglomerate, will participate in MediLedger, a blockchain consortium that tracks new drugs. On the other hand, there are voices expressing concerns about the leakage of personal information and exposure of business information about the 'transparency' as a side effect of blockchain technology.

Members of the MediLedger project, launched in 2017, include pharmaceutical company Hua, three major U.S. drug wholesalers McKesson, AmerisourceBergen and Cardinal Health. It is expected to have a significant impact on the expansion of MediLedger, as is the case of Wal-Mart's IBM Food Trust, a giant retail boasting the massive sales.

In addition, the U.S. Federal Council also makes it mandatory for the U.S. Food and Drug Administration (FDA) to provide "interoperable electronic systems for tracking and verifying prescription drugs" by 2023.

Meanwhile, MediLedger along with the U.S. FDA, has decided to launch a drug tracking test program this month. Walmart is also expected to participate in the test program, which is why blockchain and virtual currency industries are welcoming this move.

Meanwhile, Walmart has also been very active in introducing blockchain technology by joining IBM Food Trust, a food supply chain network developed by IBM on the Hyperledger Fabric platform, and sending letters to vegetable suppliers that require them to participate in IBM Food Trust, and applying for patents related to a number of blockchain, including delivery using drones in tracking product shipments.

 

James Lee 기자 (news@dailycoinews.com)의 기사 더 보기

- Daily Coin News prioritizes the voice from the scene over others(news@dailycoinews.com) -

- 기사에 사용된 모든 자료에 대한 책임은 작성자 본인에게 있습니다 -

[copyrightⓒ 2018 All rights reserved by Daily Coin News]

Bitcoin price when registering article
BTC-USD : $ 7,943.10 USD (API by Bitfinex)

2 0 Write